AstraZeneca sells right to heart failure, blood pressure medicines for $400 million

Fargo, ND, USA / The Mighty 790 KFGO | KFGO

Oct 30, 2020 | 2:26 AM

(Reuters) – AstraZeneca Plc said on Friday it had agreed to sell commercial rights for two of its heart failure and blood pressure medicines to German pharmaceutical company Cheplapharm Arzneimittel GmbH for $400 million.

Under the deal, Cheplapharm will get commercial rights for Atacand and Atacand Plus in around 70 countries globally, AstraZeneca said.

(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Sriraj Kalluvila)

2 seriously injured in motorcycle crash in southeast North Dakota

4h ago

Hope man dies in crash northwest of Pillsbury in eastern North Dakota

4h ago

Charges allege Minnesota man tried to kill his wife so she would not have to live off reduced Social Security benefits

1h ago

Walz activates National Guard to help fight wildfires

3h ago

Biden announced as keynote speaker for South Dakota Democratic event

4h ago

Minnesota Legislature closes out session marked by partisan division and election year politics

3h ago

AstraZeneca sells right to heart failure, blood pressure medicines for $400 million

Current Weather »

Fargo, ND